|
|
|
Volumn 19, Issue 3, 2009, Pages 372-380
|
|
Efficacy of new biologics on bone destruction in rheumatoid arthritis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ANTIBODY CONJUGATE;
MONOCLONAL ANTIBODY;
RITUXIMAB;
TUMOR NECROSIS FACTOR ALPHA;
B LYMPHOCYTE;
DRUG ANTAGONISM;
HUMAN;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RHEUMATOID ARTHRITIS;
T LYMPHOCYTE;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
B-LYMPHOCYTES;
HUMANS;
IMMUNOCONJUGATES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
T-LYMPHOCYTES;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 66149128130
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (15)
|
